NeuroCure Visiting Fellows and Scientists
The aim of NeuroCure's Visiting Fellows and Scientists funding program is to integrate renowned foreign scientists into the Berlin research landscape to further strengthen the international profile of the universities and research facilities, and to foster collaborative projects.
Visiting Fellows and Scientists are required to come to Berlin to participate actively in the research and teaching activities of the Cluster. This can take the form of, e.g., joint projects, the development of new technologies, or scientific lectures as a supplement to teaching.
Prof. Dr. Cheng-Chang Lien has been a NeuroCure Visiting Fellow since April 2015. He works in the laboratory of Prof. Dr. Imre Vida at the Charité Institute of Integrative Neuroanatomy.
Cheng-Chang Lien is Associate Professor of Neuroscience at National Yang-Ming University in Taiwan. Following his medical studies at the China Medical University in Taiwan, he completed his PhD in physiology/neuroscience at the University of Freiburg. He subsequently worked as a postdoc at the University of Freiburg and thereafter the UC Berkeley before moving to National Yang-Ming University. In 2012 Cheng-Chang Lien was a visiting scientist in the Institute of Physiology and Pathophysiology at the University of Heidelberg.
Cheng-Chang Lien's laboratory applies a multidisciplinary approach including electrophysiology, pharmacology, molecular biology, optogenetics and computational modeling to uncover GABAergic neuron subtype-specific properties in the hippocampus, and their possible role in neurotransmission and abnormalities in learning and memory.
Prof. Dr. Alison Lloyd has been a NeuroCure Visiting Fellow since April 2015. She works in the laboratory of Prof. Dr. Britta Eickholt at the Charité Institute of Biochemistry.
Alison Lloyd is Senior Group Leader and Professor of Cell Biology at the MRC Laboratory for Molecular Cell Biology and UCL Cancer Institute, University College London. Following PhD studies in cell and molecular biology at the Institute for Cancer Research, Chester Beatty Laboratories, London, she worked as a postdoctoral fellow at the Faculté de Médecine in Strasbourg, and thereafter as Manager of Technology Transfer at the Ludwig Institute for Cancer Research, London. Prior to her current position, she was a postdoctoral fellow at the Imperial Cancer Research Fund Laboratories in London.
Alison Lloyd's research focuses on cell biogenesis and tissue regeneration and the role of these processes in cancer, using the mammalian peripheral nervous system (PNS) as a model system. Her work is not only relevant for cancer biology, but also for the tumour predisposition syndrome, Neurofibromatosis Type 1 (NF1).
Dr. Eva Naumann has been a NeuroCure Visiting Scientist since April 2015. She works in the Bioimaging and Neurophotonics Lab of Prof. Dr. Benjamin Judkewitz at the Charité.
Since completing her PhD in neurobiology at Harvard University, Boston and Ludwig-Maximilians-Universität in Munich, she has worked as a Marie Curie Postdoctoral Fellow in the Rihel Laboratory at University College London and the Engert Laboratory at Harvard University, Center for Brain Sciences.
Eva Naumann's research uses behaviour-derived algorithmic descriptions and functional imaging to identify the neural circuit underlying a basic visually guided sensorimotor behaviour, the optomotor response (OMR), in larval zebrafish.
Prof. Dr. Hermona Soreq has been a NeuroCure Visiting Fellow since April 2015. She works in the laboratory of Prof. Dr. Andreas Meisel at the Charité Institute for Neurology.
Hermona Soreq studied molecular biology at the Weizmann Institute of Science and joined the Hebrew University in 1986. She holds the Slesinger Chair of Molecular Neuroscience and is a founding member of the Hebrew University's Edmond and Lily Safra Center for Brain Science.
Hermona Soreq's research is centered on acetylcholine functioning. She pioneered the application of molecular biology and genomics to the study of cholinergic signaling, with a recent focus on its microRNA regulation, and is interested in the checks and brain-to-body blaances of cholinergic mechanisms in health and disease.
Prof. Dr. Roger Traub has been a NeuroCure Visitng Fellow since December 2014. He works in the laboratory of Prof. Dr. Dietmar Schmitz at the Neuroscience Research Center (NWFZ) at the Charité and Prof. Dr. Michael Brecht at the Bernstein Center for Computational Neuroscience Berlin (BCCN) at the Humboldt-Universität zu Berlin.
Roger Traub studied mathematics at Princeton University and completed his medical studies at the University of Pennsylvania. Since 2001, he has been Professor for Physiology, Pharmacology and Neurology at the State University of New York. In addition, he works as a research member for IBM at the Watson Research Center.
Roger Traub is an expert in the computer simulation of circuits between cortical neurons, which are used, for example, in epilepsy research. In cooperation with the working groups of Dietmar Schmitz and Michael Brecht, Roger Traub researches rapid network oscillations and intracellular spikes and spikelets both in vitro and in vivo. Due to Traub's realistic simulations, characteristic, verifiable predictions can now be made. This enables NeuroCure scientists to carry out deeper analyses on even cryptic experimental observations.
Prof. Dr. Tony Wyss-Coray has been a NeuroCure Visiting Fellow since August 2013. He works in the laboratory of Prof. Dr. Frank Heppner at the Charité Institute for Neurophysiology.
Tony Wyss-Coray is a Professor at the Department of Neurology and Neurological Sciences, Stanford University Medical School. Following his biology studies in Bern, Switzerland, he completed a PhD in immunology at the Institute of Clinical Immunology, Faculty of Medicine, University of Bern. He subsequently joined the Scripps Research Institute in La Jolla, CA, USA and, later, the Gladstone Institute at the UC San Franicisco.
Tony Wyss-Coray's laboratory investigates immune and injury responses in aging and neurodegeneration. Dr. Wyss-Coray is recognized as an outstanding scientist in the field of neurodegeneration and Alzheimer’s disease research. He has made major contributions to the field, changing old concepts and contributing new ideas, new hypotheses, and new techniques for studying inflammation and immune responses in Alzheimer’s disease.
Former NeuroCure Visiting Fellows and Scientists
The following researchers have enriched the Berlin neuroscience landscape as NeuroCure Visiting Fellows and Scientists:
Alison L. Barth, Carnegie Mellon University, USA
Burkhard Becher, University of Zurich, Switzerland
Craig C. Garner, Stanford University School of Medicine, USA
Matthew Holt, Katholieke Universiteit Leuven, Belgium
Erik Jorgensen, University of Utah, USA
Brian MacVicar, University of British Columbia, Canada
Istvan Mody, University of California UCLA School of Medicine, USA
Israel Sekler, Ben-Gurion University, Israel